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Background: UDP-glucose dehydrogenase 
(UGDH) mutants were engineered to perturb 
hexamer:dimer quaternary structure equilibrium. 
Results: Dimeric species of UGDH have reduced 
activity in vitro and in supporting hyaluronan 
production by cultured cells. 
Conclusion: Only dynamic UGDH hexamers 
support robust cellular function.  
Significance: Manipulation of UGDH activity by 
hexamer stabilization may offer new therapeutic 
options in cancer and other pathologies.  
 
SUMMARY 
UDP-glucose dehydrogenase (UGDH) provides 
precursors for steroid elimination, hyaluronan 
production, and glycosaminoglycan synthesis. 
The wild-type UGDH enzyme purifies in a 
hexamer-dimer equilibrium, and transiently 
undergoes dynamic motion that exposes the 
dimer-dimer interface during catalysis. In the 
current study, we created and characterized 
point mutations that yielded exclusively dimeric 
species (obligate dimer, T325D), dimeric species 
that could be induced to form hexamers in the 
ternary complex with substrate and cofactor 
(T325A), and a previously described exclusively 
hexameric species (UGDHΔ132), to investigate 
the role of quaternary structure in regulation of 
the enzyme.  Characterization of the purified 
enzymes revealed a significant decrease in the 
enzymatic activity of the obligate dimer and 
hexamer mutants. Kinetic analysis of wild-type 
UGDH and the inducible hexamer, T325A, 
showed that upon increasing enzyme 
concentration, which favors the hexameric 
species, activity was modestly decreased and 
exhibited cooperativity. In contrast, cooperative 
kinetic behavior was not observed in the 
obligate dimer, T325D.  These observations 
suggest that the regulation of the quaternary 
assembly of the enzyme is essential for optimal 
activity and allosteric regulation. Comparison 
of kinetic and thermal stability parameters 
among the hexameric wild-type enzyme and the 
engineered mutants revealed structurally-
dependent properties consistent with a role for 
controlled assembly and disassembly of the 
hexamer in the regulation of UGDH.  Finally, 
both T325A and T325D mutants were 
significantly less efficient in promoting 
downstream hyaluronan production by 
HEK293 cells.  These data support a model that 
requires an operational dimer-hexamer 
equilibrium in order to function efficiently and 
preserve regulated activity in the cell.  
 
UDP-glucuronate is an essential cellular 
metabolite that serves as the precursor for multiple 
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diverse and compartmentalized processes.  
Notably, its production is critical in tissues such as 
liver, prostate, and breast for ER-localized phase II 
detoxification of lipophilic hormones and 
xenobiotics by glucuronidation (1).  In adult 
tissues, in wound healing, and during 
development, high levels of UDP-glucuronate are 
used to synthesize extracellular glycosamino-
glycans such as heparan sulfate and hyaluronan 
(HA)(2), and the decarboxylation of UDP-
glucuronate to UDP-xylose initiates proteoglycan 
production in the Golgi (3).  In embryonic 
development, temporal and spatial elevation in 
UDP-glucuronate synthesis are indispensible for 
rapid extrusion of HA to the extracellular space to 
effect the dramatic morphological changes that 
generate anatomical structures such as cardiac 
valves (4,5). 
UDP-glucuronate is exclusively synthesized 
by UDP-glucose dehydrogenase (UGDH), which 
is an essential enzyme for circulatory system 
development in multiple organisms from 
nematodes to humans (4,6-11).  In prostate tumor 
cell lines, UGDH is a constitutively expressed but 
androgen-stimulated gene product, upregulation of 
which can specifically drive excess steroid 
elimination through glucuronidation in hormone 
dependent cells (12).  In the developing heart, 
UGDH point mutations that alter the integrity of 
quaternary structure, normally hexameric, fail to 
support maximal HA production that is needed for 
cardiac valve formation (4).  Clinical and cellular 
consequences associated with UGDH defective 
function implicate stable but dynamic association 
of subunits, and suggest useful therapeutic 
applications would focus on sustaining robust 
UGDH activity. 
Several reports have provided structural and 
enzymological insights into UGDH function in 
multiple species (6,7,10,11,13-26).  In all cases, 
the enzyme oxidizes UDP-glucose through two 
NAD+-dependent electron transfers.  Of particular 
interest to studies relating quaternary structure to 
cellular function is that bacterial UGDH adopts a 
strictly dimeric conformation in the presence or 
absence of its substrate and cofactor (27), whereas 
higher eukaryotic UGDH orthologues purify in a 
hexamer-dimer equilibrium that is stabilized to 
hexameric association under conditions 
representative of the cellular environment 
(4,11,16,28).  Kinetic data comparing wild-type 
UGDH to an obligate (inactive) hexamer mutant in 
which residue 132 was deleted (25), together with 
the interesting observation of an “open” 
conformation of the wild-type enzyme observed in 
co-crystals with the potent UGDH inhibitor UDP-
xylose, suggest that the transient capacity to 
dissociate and reorganize the hydrogen bond 
network at the interface between dimeric units is 
an important element of the enzyme’s normal 
catalytic cycle. 
For the current study, we sought to determine 
the effects of quaternary structure on intrinsic and 
cellular functional properties of UGDH.  
Crystallographic data are available for several 
wild-type or point mutant UGDH forms (pdb 
codes 3ITK (29) and 3KHU (30)), including an 
apo structure, as well as ternary forms with each 
permutation of the abortive complex (NAD+ 
cofactor and UDP-glucuronate product, 2QG4; 
NADH cofactor and UDP-glucose substrate, 2Q3E 
(29)).  These structural data provide a high 
resolution view of the non-covalent bonding 
network that sustains the subunit interface in the 
context of the hexamer (Fig 1).  We used these 
coordinates to rationally generate point mutations 
expected to perturb the interface and alter the 
hexamer-dimer equilibrium without impacting 
catalytic activity directly.  With these tools, we 
additionally evaluated whether the hexameric 
conformation is required for cellular function, and 
how its integrity relates to steady state activity.  
Our results demonstrate for the first time that the 
UGDH hexamer is more competent to support 
high levels of HA production than the dimer, and 
that intrinsic stability of the enzyme is 
conformationally dependent.     
 
EXPERIMENTAL PROCEDURES 
Generation and purification of UGDH point 
mutants.  Molecular graphics and analyses were 
performed with the UCSF Chimera package (31), 
developed by the NIH-supported Resource for 
Biocomputing, Visualization, and Informatics at 
the University of California, San Francisco.  Point 
mutants of human UGDH were generated from the 
wild type construct, UGDH-pET28a (for protein 
purification), using the QuikChange site-directed 
mutagenesis kit (Stratagene, La Jolla, CA) 
according to the manufacturer’s protocol.  
Sequences were verified by Eurofins MWG 
Operon (Huntsville, AL).  Wild-type UGDH and 
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point mutants were expressed in E. coli strain 
Rosetta2(DE3)pLysS (EMD Biosciences, Inc., San 
Diego, CA), induced overnight at 18˚C, and 
purified as N-terminal 6-His fusions essentially as 
previously described (11).  Following nickel 
affinity chromatography, proteins were dialyzed 
against 20mM Tris-HCl, pH 7.4, and 1mM DTT.  
Protein was stored at a concentration of 2 mg/ml. 
Enzymatic activity measurement and kinetic 
characterizations. Activity of the point mutants 
was assayed by monitoring the change in 
absorbance at 340 nm that accompanies reduction 
of NAD+ to NADH as reported previously (11).  
For standard measurement of enzymatic activity, 
the assay was done in a 96-well plate format at 
room temperature for 5 minutes in 0.1 M sodium 
phosphate buffer, pH 7.4.  T325A and T325D 
mutants exhibited saturable kinetics, while the 
activity of the ∆132 mutant was found to be 
negligible.  Michaelis constants Km and Vmax, for 
UDP-glucose and NAD+, were determined 
independently by holding [NAD+] constant at 10 
mM and varying [UDP-glucose] from 0-1 mM.  
Similarly, NAD+ measurements were made by 
holding [UDP-glucose] constant at 1 mM and 
varying [NAD+] from 0-10 mM.  Specific 
activities were calculated from absorbance values 
using the molar extinction coefficient for NADH 
of 6220 M-1cm-1.  Triplicate determinations for 
each concentration increment were plotted with 
PRISM (GraphPad Software, Inc., San Diego, 
CA).  Km and Vmax were calculated by fitting the 
data to the Michaelis-Menten equation and 
assuming a single binding site per subunit for 
substrate and cofactor.   
Stability of enzyme activity in vitro. Wild type 
and mutant UGDH (1mg/mL each in 0.1M sodium 
phosphate, pH 7.4) was incubated in the absence 
and presence of saturating NAD+ (10mM) and 
UDP-glucuronate (1mM).  After a 1 minute 
equilibration at 37˚C, aliquots were assayed for 
initial activity as above with saturating NAD+ and 
UDP-glucose, and a final enzyme concentration of 
670nM.   For each time point, absorbances were 
measured in triplicate, divided by the average 
absorbance at time zero, and plotted as percent 
relative activity over time.  Using PRISM 
software, the graphs were fitted to the one phase 
exponential decay equation in order to calculate 
half-lives at 37˚C.  
Molecular Mass Determination.  Oligomeric 
state of the apo enzyme was determined by size 
exclusion chromatography as previously described 
(11).  Each sample was precleared by 
centrifugation prior to loading.  To determine the 
effect of substrate and cofactor inclusion on 
oligomeric state, purified recombinant UGDH 
wild-type and point mutants were individually 
loaded on a Superdex 200 HR 10/300 column (GE 
Healthcare Life Sciences, Piscataway, NJ) using a 
250 μL loop and separated by FPLC in 1X PBS in 
the presence of 1 mM UDP-glucose and/or 5 mM 
NAD+ at a flow rate of 0.5 ml/min.  Substrate and 
cofactor alone or together were included in each 
250 μL load sample at the same final 
concentrations.  Because of the interference from 
cofactor in UV absorbance readings from the 
column fractions of enzyme complexes, protein 
content of these samples was measured at 595 nm 
upon the addition of Bradford reagent. The 
standards used were: thyroglobulin, 699 kDa; 
ferritin, 440 kDa; albumin, 67 kDa; β 
lactoglobulin, 35 kDa; RNase A, 13.7 kDa.  
Resolution was sufficient to calculate molecular 
masses unambiguously in multiples of 57 kDa (the 
calculated molecular mass of monomeric His-
tagged UGDH). 
Thermal stability measurement. Purified 
recombinant UGDH wild-type and point mutants 
were analyzed using a modified version of the 
Thermofluor Stability Assay as described by 
Ericsson et al (32).  Solutions of the wild-type and 
mutant apo enzymes (~5-20 μg of protein) were 
prepared in 1X PBS containing Sypro Orange dye 
(Invitrogen, 1:500 dilution).  Samples containing 
substrate and/or cofactor were prepared in the 
same manner with UDP-glucose and NAD+ added 
to a final concentration of 1 mM and 5 mM 
respectively.  All samples were handled at room 
temperature throughout the preparation and 
transferred to an iCycler MyiQ Thermocycler 
(Bio-Rad) for analysis.  The assay protocol was 
executed with the block initially at 20°C.  After 
addition of samples, temperature was raised over a 
period of 76 min from 20°C to 95°C in 0.5°C 
increments.  The change in fluorescence was 
monitored for each sample at an excitation and 
emission of 490 and 575 nm respectively.  
Transitions representing the melting temperature, 
Tm, were obtained from the derivative of 
fluorescence with respect to temperature for at 
least 3-10 replicates, and plotted as the mean ± 
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SD. 
Proteolytic sensitivity of UGDH. Purified 
recombinant UGDH wild-type and point mutants 
(10 μg protein) were digested with 10 ng of 
trypsin in 1x PBS for 2.5 hours in the absence or 
presence of 1mM UDP-glucose, 1mM UDP-
glucuronate, 5mM NAD+, 5 mM NADH, or 
abortive ternary complexes (at saturating 
conditions).  Samples were analyzed by reducing 
SDS-PAGE.  
Cell Culture and Transfection. HEK293 cells 
were cultured in DMEM supplemented with 10% 
fetal bovine serum (FBS, Fisher), and seeded in a 
6-well plate 24 hours prior to transfection. Cells 
were transiently co-transfected at 80% confluence 
using Fugene HD (Roche) with hyaluronan 
synthase 3 (HAS3) and wild-type or mutant 
UGDH constructs in the pIRES2-EGFP eukaryotic 
expression vector.  Cells were harvested 48 hours 
post-transfection in 1X RIPA buffer and incubated 
on ice for 10 minutes.  The whole cell lysate was 
separated by centrifugation. 
HA Quantification and Western Analysis. HA 
content of cell culture conditioned media was 
determined by a competitive binding assay (23). 
Human umbilical cord HA (Sigma) was coupled to 
Covalink 96-well plates at 100 μg/ml in 1X PBS 
in the presence of 25μg SulfoNHS/EDC.  Plates 
were rocked for 1.5 h at room temperature, then 
washed twice with Pierce SuperBlock prior to 
sample incubation.  Serial dilutions of cell culture 
media were incubated with biotinylated HA 
binding protein (bHABP, Calbiochem) at a final 
concentration of 1 μg/mL.  Standards and samples 
were incubated in the HA-precoated wells at room 
temperature overnight.  Excess HA was removed 
with four washes of PBS/0.05% Tween 20.  The 
plate was developed using an avidin-biotin HRP 
system (Vectastain) with TMB as substrate, and 
absorbance was measured at 650 nm.  HA 
concentration was interpolated from a standard 
curve and normalized to total protein. Western 
analysis of whole transfected cell lysates was 
performed as previously described (24).  Primary 
antibodies were used at a dilution of 1:1000 for α-
UGDH and α-FLAG, and 1:750,000 for α-tubulin. 
 
RESULTS 
Kinetic comparison of wild-type and mutant 
UGDH.  To determine the role of quaternary 
structure in the activity and properties of UGDH, 
we designed, expressed, and purified mutant 
species of the enzyme that were expected to 
exhibit disruption from primarily hexameric to 
exclusively dimeric association.  Initially, we 
selected glutamate 110 and threonine 325 because 
of their pivotal functions in dimer-dimer 
association as shown in the ribbon diagram of the 
ternary complex structure (Fig 1).  The E110A 
mutant, although dimeric in the apo form, 
exhibited only about 50% reduction in Vmax, but 
was highly unstable in solution and in cultured 
cells, so it could not be evaluated unambiguously.  
The carboxylate side chain of this residue on one 
subunit forms salt bridges with two positively 
charged moieties, one of which is on the adjacent 
subunit (K329) and one of which stabilizes the 
same helix that contains E110 (R114, Fig 1).  
Therefore, the loss of E110 not only disrupts a 
direct series of interactions between subunits, but 
also within individual subunits, since this charge 
likely screens electrostatic repulsion between the 
two positive charges.  This may account for its 
instability.  Instead, we pursued the other highly 
networked interface residue, T325.   
In the apo form, T325 directly forms a 
hydrogen bond with D105 of the opposite subunit 
(Fig 1B).  A similar view of the interface in the 
abortive ternary complex structure illustrates a 
conformational change that reorganizes the 
hydrogen bond network such that T325 and D105 
now coordinate through a highly ordered water 
molecule (Fig 1C).  T325 residue was altered to an 
alanine because it would be incapable of hydrogen 
bonding, and to aspartate, which would introduce 
a new formal negative charge at the interface.  
Both mutants expressed abundant soluble protein, 
similarly to the wild-type enzyme, and exhibited 
saturable kinetics.  Data were fitted to the 
Michaelis-Menten equation to calculate steady 
state kinetic constants and evaluate potential 
cooperativity.  Wild-type UGDH and the T325A 
mutant exhibited similar Vmax and Km values with 
respect to both substrate and cofactor when 
examined under standard assay conditions (Table 
1).  However, the T325D mutant exhibited 
approximately 5-fold reduced Vmax relative to the 
wild-type UGDH.  Interestingly, when the wild-
type and T325A mutant enzyme were assayed at 
higher concentrations, previously reported to yield 
sufficient NADH to inhibit activity (Ki for NADH 
= 27μM (21)), the turnover and catalytic 
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efficiency of both were significantly reduced (Fig 
2).  In contrast, the efficiency of the T325D 
mutant was not altered over this enzyme 
concentration range, despite accumulation of 
NADH to the previously reported inhibitory levels 
and an unaltered apparent Km for NAD+ relative to 
the wild-type enzyme.  These results suggest the 
perturbation of the dimer interface by charge 
introduction eliminates negative cooperativity and 
product inhibition.   
Half-life of UGDH catalytic activity in vitro is 
reduced by mutations at the dimer interface.  We 
previously observed a loss of stability in the 
catalytic activity of UGDH when quaternary 
structure was disrupted by mutations that were 
found in human congenital heart defects.  
However, we were not able to assert 
unambiguously that the loss of activity was 
attributable to the effects of those mutations on 
UGDH quaternary structure.  The T325 mutants 
afforded this opportunity, since they were 
rationally designed to disrupt hexamer assembly 
without directly affecting the integrity of the 
active site.  In addition, we had not tested the 
effect of substrate and cofactor concentrations that 
simulated cellular conditions on overall duration 
of the enzyme’s catalytic competence.  Purified 
wild-type or mutant UGDH was incubated with or 
without NAD+ and UDP-glucuronate, an abortive 
ternary complex, and activity was monitored over 
time.  Formation of the wild-type ternary complex 
extended the half-life of enzymatic activity ≈30% 
from 59h to 88h (Fig 3A).  The activity of the 
T325A mutant was the most labile, with a half-life 
of only 24h that was not extended significantly by 
substrate and cofactor addition (Fig 3B).  
Interestingly, UGDH T325D retained its activity 
similarly to the wild-type enzyme but did not 
exhibit increased stability in the abortive ternary 
complex (Fig 3C).  
UGDH quaternary structure disrupted by 
mutagenesis of T325 is differentially restored by 
ternary complex formation.  We directly assessed 
the quaternary structure of the T325 mutants by 
size exclusion chromatography.  As expected, the 
wild-type enzyme purified in a hexamer-dimer 
equilibrium that was stabilized to the hexamer 
conformation by inclusion of saturating NAD+ 
cofactor and UDP-glucose substrate in the column 
running buffer.  Moreover, we further found that 
the presence of either substrate or cofactor alone 
was also able to shift the eluted peak to the higher 
mass profile of the hexamer (Fig 4).  As a control, 
we generated an additional point mutant, ∆132, in 
which valine 132 was deleted and which had been 
reported to be exclusively hexameric (25).  
Consistent with the prior results, this mutant had 
undetectable activity (Table 1) and eluted at the 
molecular mass of the hexamer, irrespective of 
substrate or cofactor addition.  In contrast, both 
T325A and T325D mutants were exclusively 
dimeric in the apo form, indicating the loss of the 
neutral hydrogen bond network formed by T325 
was sufficient to disrupt the dimer-dimer 
association interface.  However, the inclusion of 
either substrate or cofactor alone with UGDH 
T325A partially shifted the dimer equilibrium to 
higher molecular mass complexes, and addition of 
both to form the ternary complex fully shifted the 
peak to the molecular mass of the hexamer.  
Neither the presence of substrate or cofactor alone, 
nor the inclusion of both together, effected any 
change in the apparent molecular mass of the 
T325D mutant, which retained its dimeric 
structure.  Thus, we termed the UGDH mutant 
∆132 an obligate hexamer, T325A an inducible 
hexamer, and T325D an obligate dimer. 
Intrinsic thermal stability and resistance to 
proteolysis are reduced by inability of UGDH to 
hexamerize.  With these tools in hand, we sought 
to assess whether structural properties of the 
mutants were altered so that we could relate the 
intrinsic characteristics to the activity of the 
enzymes in vitro and in vivo, and draw 
conclusions about the importance of hexameric 
conformation to cellular function.  A thermal 
denaturation assay was previously used to show 
that the melting temperature (Tm) of the UGDH 
apoenzyme was increased by 20˚C in the presence 
of saturating substrate and cofactor to form the 
holoenzyme (4,29).  We extended our prior 
characterization of the wild-type enzyme using 
this assay in the presence of either reduced or 
oxidized cofactor alone, substrate or product 
alone, and each permutation of the ternary 
complex (e.g.; UDP-glucose and NAD+, UDP-
glucuronate and NAD+, etc.).  As expected, the 
ternary complexes exhibited ≈20˚C higher Tm 
relative to the wild-type UGDH apoenzyme (Fig 5, 
solid dark bars compared to the white bar).  
However, adding either cofactor, substrate, or 
product alone also increased thermal stability, 
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though to a lesser extent (≈10˚C, Fig 5, patterned 
bars).  Consistent with the maximal thermal 
stabilization being attributable to the ability to 
hexamerize, the UGDH ∆132 mutant had a Tm 
equivalent to the wild-type ternary complex, with 
or without any additives.  The Tm of the UGDH 
T325A mutant was not altered by addition of 
substrate or cofactor alone, but was increased by 
≈20˚C in each of the ternary complexes, which 
would be predicted by its apparent hexameric 
conformation in the gel filtration assay.  The 
T325D mutant, also as predicted, was not 
stabilized by substrate or cofactor alone in the 
thermal denaturation assay, but the Tm increased 
≈10˚C in the ternary complexes, suggesting there 
is some intrinsic stability conferred even to the 
dimeric species that is independent of dimer-dimer 
association.  However, this demonstrates that the 
hexameric wild-type UGDH enzyme has greater 
potential to be stabilized in the presence of its 
metabolites than does the obligate dimer mutant. 
As an independent measure of structural 
integrity in vitro, we evaluated susceptibility of 
each wild-type and mutant UGDH species to 
limited trypsin proteolysis.  We chose conditions 
in which the wild-type enzyme was almost 
completely degraded in the apo form (Fig 6, top, 
first two lanes).  As observed in the thermal 
denaturation assay, addition of substrate, product, 
reduced or oxidized cofactor, or each permutation 
of ternary complex components fully protected the 
wild-type enzyme against proteolysis.  Similarly, 
the obligate hexamer UGDH ∆132 was minimally 
susceptible to trypsinization in all conditions.  The 
inducible hexamer, T325A, was fully degraded in 
the apo form and in the presence of substrate 
alone.  Addition of NAD+ stabilized the enzyme 
fully, and either NADH or UDP-glucuronate 
partially protected, while the ternary complexes 
were almost completely undigested.  These results 
are consistent with the T325A mutant’s ability to 
adopt a hexameric conformation that is thermally 
and proteolytically stabilized to an increasing 
degree upon cofactor and substrate addition.  Not 
surprisingly, the T325D obligate dimer mutant 
was fully degraded by trypsin in the apo form and 
in the presence of substrate, product or cofactor 
individually.  Consistent with an increase in its 
intrinsic subunit stability though without the 
ability to hexamerize, the T325D mutant 
experienced only partial protection against trypsin 
digestion in the ternary complex. 
Cellular function of UGDH is dependent on 
hexameric stability.  Though cellular ratios of 
NAD+/NADH and UDP-glucose/UDP-glucuronate 
are likely to undergo considerable flux depending 
upon local or systemic nutrient and oxygen status, 
the pool of NAD cofactors in a given cell type is 
relatively fixed.  Therefore, we compared the 
effects of obligate and inducible quaternary 
structure on the ability to provide precursors for 
HA synthesis in a cellular context.  HEK293 cells, 
which express very low endogenous UGDH and 
HA synthase (HAS), the enzyme that uses UDP-
glucuronate to produce HA, were transfected with 
eukaryotic expression constructs for wild-type or 
mutant UGDH, with or without HAS3.  Equivalent 
steady state expression of all UGDH species was 
observed in each transfection condition (Fig 7, 
upper panel).  HA was quantified in the 
conditioned media of each transfectant and 
normalized to total protein in the transfected cell 
lysate analyzed by western in the upper panels.  
Concurrent expression of wild-type UGDH and 
HAS3 yielded ≈3-fold more HA production than 
transfection with HAS3 alone, as we have 
previously observed (12).  Strikingly, expression 
of the T325A mutant with HAS3 was not fully 
effective in promoting HA synthesis, yielding 
approximately 60% less HA than the wild-type 
cotransfection.  The UGDH T325D mutant did not 
support HA production in excess of HAS3 alone, 
and coexpression of HAS3 with the obligate 
hexamer ∆132 modestly but significantly 
suppressed HA production relative to HAS3 alone.  
Thus, the cellular activity of UGDH is maximized 
when its conformational sampling statistically 
favors the hexameric species but permits dynamic 
movements in quaternary structure.  These results 
support a model in which the hexamer-dimer ratio 
of UGDH senses flux in the presence of cellular 
cofactor, substrate and product.   
 
DISCUSSION 
UGDH targeted disruption and loss of 
function polymorphisms that interfere with the 
enzyme’s quaternary structure and cellular 
stability have been implicated in cardiac 
malformation in multiple organisms (4,5,33,34).  
Moreover, the androgen-stimulated expression of 
UGDH is important for prostate epithelial 
androgen solubilization and elimination.  Our goal 
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was to engineer obligatory forms of the enzyme 
that represented its two most stably sampled 
oligomeric states, while minimally disrupting 
overall or active site stability, to determine the 
mechanistic function of this hexamer-dimer 
equilibrium in vitro and in a cellular context.  The 
engineered UGDH mutants allowed us to 
determine that the hexameric enzyme has only 
modestly greater maximal catalytic activity than 
the dimer, but is significantly more responsive to 
structural stabilization and activation by substrate 
and cofactor, and capable of supporting greater 
output of the extracellular matrix product HA.  
Importantly, however, the dimeric mutant retains 
significant activity and is considerably less 
sensitive to product inhibition by reduced cofactor. 
Examination of the dimer-dimer subunit 
interface revealed an extensive network of charge 
interactions and hydrogen bonding that 
coordinately stabilize the hexamer in the presence 
and absence of its cofactor or substrate.  Besides 
T325, we had also identified a glutamate residue, 
E110, as a critical contributor to non-covalent 
interactions.  However, the intrinsic instability of 
the E110A mutant made it unsuitable for 
subsequent cellular studies.  T325 is ideally 
positioned to accommodate reorganization of the 
interface hydrogen bonds that occurs as the active 
site shifts to form binary and ternary complexes, 
and exchange cofactors, during the catalytic cycle.  
Although elimination of the hydroxyl by 
substituting alanine for threonine was expected to 
prevent dimer-dimer association, stability of the 
hexamer in the ternary complex indicates that 
there was sufficient redundancy and flexibility in 
the network to prevent loss of activity.  Placement 
of a negative charge was necessary and sufficient 
to prevent subunit association, since the new 
negative charge was proximal to both the D105 
and E110 side chains of the adjacent subunit, 
which probably was electrostatically repulsive. 
It was important to characterize the mutants 
sufficiently to ascertain that an obligate dimer had 
been achieved since we had previous mutants that 
purified in a dimeric form as an apoprotein and 
later we discovered that although they had activity, 
they also had restored hexameric structure in the 
active ternary complex.  K339A purified as a 
dimer, but had been designed as a substrate 
binding mutant.  Consistent with this, its Vmax was 
identical to the wild-type enzyme but the Km for 
UDP-glucose was increased several hundred-fold.  
We interpreted this to mean that the dimeric form 
of the enzyme was equally active, but we did not 
characterize the solution oligomerization state of 
the ternary complex.  In contrast, a previously 
reported mutant, K94E, was described as a dimer 
with 100-fold reduced activity, and was used to 
argue that the dimeric species was inactive (26).  
The Km for both substrate and cofactor was also 
elevated 1-2 orders of magnitude, so the mutant 
was severely compromised, but the conformation 
of the ternary complex was also not verified.  
Inspection of the positioning of K94 at the dimer-
dimer interface reveals that its side chain directly 
forms hydrogen bonds with the E360 side chain 
and the M98 backbone carbonyl of the opposite 
subunit, and that within its own subunit, its 
backbone amide and carbonyl hydrogen bond with 
the backbone carbonyl of A103 and the backbone 
amide of G101, respectively.  Significantly 
increased disorder is evident for residues 88-110.  
Thus, residue K94 is critically involved in 
stabilization of a major element of secondary 
structure that directly communicates with the 
active site.  For these reasons, the K94E dimer did 
not unambiguously address the relation of UGDH 
quaternary structure to its function in vitro and is 
also not suitable for studies in vivo.  Our finding 
that substrate, product, and/or cofactor addition to 
either the wild-type or T325A mutant UGDH 
could partially or completely shift the structural 
equilibrium to the hexameric species led us to 
examine multiple features of the enzyme that 
could report on its structural integrity in reaction 
conditions.  In particular, we wanted to identify a 
mutant that was minimally perturbed on an overall 
structural level other than being unable to 
oligomerize.  In doing so, we affirmed that the 
dimeric species had reduced catalytic activity but 
not as a consequence of altered substrate or 
cofactor affinity in the context of the reaction. 
Gel filtration shows UDP-glucose alone and 
NAD alone stabilize the wild-type hexamer.  
However, the T325A mutant was only induced to 
form a hexamer if both substrate and cofactor were 
present.  In addition, induction of T325A hexamer 
formation required concentrations of substrate and 
cofactor that were saturating for wild-type UGDH 
and for maximal catalytic rate in the T325A 
mutant.  In these conditions, the hexameric 
conformation of T325A is then fully stabilized.  In 
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contrast, the obligate dimer remains dimeric in all 
conditions.  When we compare to thermal 
stability, there is a strong increase in melting 
temperature of the wild-type when substrate, 
product, or cofactor are added alone, and an 
additional increase when either a productive or an 
abortive ternary complex is formed.  An 
interpretation of increased stability in the 
hexameric form is further supported by the 
observed protection from proteolysis, with all of 
the binary and ternary permutations tested, as well 
as in the obligate hexameric mutant.  Results of 
proteolysis and thermal denaturation further 
support only a partial restoration in complex 
formation and its resultant increase in stability for 
the T325A mutant as indicated in gel filtration, 
and suggest greater intrinsic structural stability is 
conferred by cofactor binding than by UDP-
glucose binding.  Also consistently, the ternary 
complexes of T325A and wild-type UGDH are 
equally stable when assessed both by thermal 
denaturation and limited proteolysis.  The obligate 
dimer shows no intrinsic increase in thermal or 
proteolytic resistance except in the ternary 
complex, which suggests that approximately half 
the increase in quantified stability parameters is 
due to stability of the dimer, and half is the result 
of further ability to hexamerize.  Moreover, since 
the UDP-glucose substrate and UDP-glucuronate 
product minimally protected the T325A mutant 
against proteolysis, the stability conferred in the 
dimeric ternary complex likely derives from the 
binding of cofactor following substrate 
association. 
Previous kinetic data have shown that 
substrate binds first, with cofactor more surface 
exposed to facilitate exchange during catalysis 
(30).  This is consistent with the above proteolytic 
results, and together with the observed product 
inhibition in the hexameric form, suggests that the 
availability of the substrate may be a key 
regulatory condition.  The cooperative rate 
increase of the enzyme in the presence of 
increasing substrate is evidence that a 
conformational shift may precede achievement of 
full catalytic potential.  In addition, it has been 
suggested that the dynamic hexamer is the relevant 
catalytic species on the basis of relatively low 
activity in both the K94E dimer and the ∆132 
obligate hexamer.  Our results with a single 
substitution at position T325 are consistent with 
lower activity of the obligate dimer, but with a 
more modest reduction in turnover than in K94E.  
This retention of significant catalytic activity in 
the less perturbed T325D dimeric mutant suggests 
the dimeric species may also be catalytically 
relevant in some cellular conditions, particularly in 
the presence of product inhibition, but does not 
negate the more significant role of the hexamer 
during maximum cellular demand.   
 The wild-type enzyme overexpressed in cells 
transfected with HA synthase, which exhibit a 
high demand for HA production, generates a 3-
fold increase in achievable steady state HA levels. 
In contrast, the T325D obligate dimeric and ∆132 
obligate hexameric enzyme species were unable to 
support the acute increase in cellular demand for 
HA precursors to any detectable extent, which 
suggests that in the cellular context, neither a 
dimeric nor a hexameric conformation can be 
exclusively considered the catalytically relevant 
species.  This is not surprising, since the 
transiently dissociable interface of the wild-type 
enzyme is likely essential for cofactor exchange 
between the two oxidation events that occur in a 
single turnover.  However, it is interesting that the 
T325A mutant has equivalent steady state kinetic 
parameters to the wild-type UGDH enzyme and a 
comparable ternary complex stability, but 
demonstrates reduced support for HA production.  
We attribute this to the increased lability of the 
dimer-dimer interface in cellular conditions that 
normally support activity, since the individual 
substrate/cofactor dissociation events leave the 
subunits more susceptible to loss of maximally 
active hexameric conformation.  The equilibrium 
between hexamer and dimer presumably does not 
imply full dissociation in the cell but rather 
involves a spectrum of enzyme species with 
transiently exposed regions of the dimer-dimer 
interface.  At cellular levels of substrate, cofactor, 
and product, the exposure of the wild-type enzyme 
interface is likely to be low frequency, in 
consideration of our observation that these 
individual components stabilize all properties we 
measured for the hexameric conformation.  Since 
the T325A mutant is not fully stabilized to a 
hexamer when only one of these components is 
present, and is minimally stabilized if any 
component is subsaturating, this mutant may be 
considerably less functional in the cell as a result 
of increased dissociation.  One additional 
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explanation may be that the subunit interfaces of 
the intact hexamer versus the hexamer with a 
transiently dissociated but catalytically engaged 
dimer interface may interact differently with other 
cellular regulatory factors.  Such interactions 
could covalently or non-covalently modify the 
subunit interface to favor or discourage subunit 
association and thereby alter activity of the 
enzyme. 
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FIGURE LEGENDS 
Figure 1. Overall diagram of UGDH and the molecular interactions at the subunit interface. (A) The 
human hexameric enzyme is depicted in a ribbon representation of the ternary complex.  Active sites 
contain the substrate UDP-glucose and the reduced cofactor NADH, which are shown in ball and stick 
form.  Residue T325, which was mutagenized in this study, is shown in space-filling form and colored 
gold.  Individual subunits are colored in dimeric pairs of dark/light blue, dark/light green, and dark/light 
purple. The closeup views show proximal ordered water molecules and hydrogen bonded amino acid side 
chains that interact to maintain integrity of the subunit interface.  Black lines indicate hydrogen bonds, 
nitrogen atoms are colored blue, and oxygen atoms are red.  Ordered water molecules are depicted as red 
spheres. (B) Apoprotein interface, pdb 3itk. (C) Abortive ternary complex interface, pdb 2Q3E.  Figure 
representations were made in Chimera (31).  
 
Figure 2. Steady state kinetic analysis reveals selectively reduced catalytic activity and relief from 
product inhibition by perturbation of threonine 325.  Purified recombinant human UGDH wild-type and 
T325 mutants were assayed for concentration dependence of (A) turnover number (kcat), (B) Km, and (C) 
catalytic efficiency (kcat/Km) with respect to UDP-glucose in the presence of saturating NAD+. 
 
Figure 3. Half-life of wild-type but not mutant UGDH activity in vitro is stabilized by formation of a 
ternary complex.  Purified proteins were placed at 37˚C in the absence (apo, circles, solid line) or 
presence (holo, squares, dotted line) of UDP-glucuronate and NAD+.  At the indicated time points, an 
aliquot was removed and activity was assayed by addition of the enzyme to phosphate buffer containing 
saturating concentrations of NAD+ and UDP-glucose.  Values plotted are the mean ± SD for triplicate 
determinations.  Absolute turnover was measured as the change in NADH absorbance at 340 nm in a 1-
min assay.  Absorbance values were normalized to the value at time 0 to illustrate the rate of activity loss.  
Half-lives were calculated from curve fits of the data from triplicate assays. 
 
Figure 4. Quaternary structure of wild-type UGDH and T325A is stabilized from dimeric to hexameric by 
substrate and cofactor while T325D remains an obligatory dimer.  Purified wild type and mutant UGDH 
was fractionated by gel filtration FPLC in the absence (dark solid line) or presence of NAD+ alone (gray 
hatched line), UDP-glucose alone (gray dotted line), or both (dark hatched line).  Absorbance was 
monitored at 280 nm for the apoproteins (left ordinate axis) and 595 nm for the holoproteins (right 
ordinate axis).  Size determination of each peak was made by comparison to molecular weight standards.  
Representative traces are plotted for wild-type UGDH, ∆132, T325A, and T325D.  On each plot, the 
peaks corresponding to hexamer and dimer are labeled H and D, respectively.  
 
Figure 5. UGDH is thermally stabilized by addition of substrate and cofactor but thermal stability is 
compromised by mutations that occur at the dimer interface.   Purified wild type UGDH and point 
mutants were thermally denatured in the presence of Sypro Orange by increasing temperature from 20˚C 
to 95˚C in 0.5 °C increments.  The change in fluorescence with respect to temperature was used to 
calculate a melting point (Tm) for each enzyme species in the absence (white bars) or presence of 5 mM 
NAD+  or NADH, 1 mM UDP-glucose or UDP-glucuronate, and each of three ternary complex 
combinations, as indicated in the legend.  Mean ± SD is plotted for the Tm of each enzyme. 
 
Figure 6. Differential sensitivity to limited proteolysis reveals altered conformation conferred to the 
mutant UGDH enzymes by impaired ability to assemble in hexamers.  Purified wild-type and mutant 
UGDH was prepared in the absence or presence of the indicated substrate and/or cofactor combinations 
and then treated with trypsin and analyzed by SDS-PAGE.  Results are representative of at least three 
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different experimental replicates. 
 
Figure 7. Loss of UGDH intrinsic activity impacts cellular HA production.  HEK293 cells were 
cotransfected with constructs encoding GFP (vector control) and human HAS3, or GFP and wild-type or 
mutant UGDH, or with HAS3 and each UGDH construct.  After 48 hours, conditioned media were 
analyzed for HA content and cell lysates were analyzed by western for UGDH, HAS3 (Flag), or tubulin 
(control).  HA was calculated in units of mass per volume of conditioned medium, and normalized to 
protein content (in mg) of the whole cell lysates.  Mean ± SEM is plotted for quadruplicate measurements 
repeated three times.  Statistical significance was evaluated by Student’s t-test; * p<0.01, ** p<0.05, 
relative to HAS3 only.  Western data are shown for the relevant lysates.  
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Table 1.  Summary of wild type and mutant UGDH kinetic constants. 
Enzyme 
UDP-Glucose NAD+ 
Vmax 
nmol/min/mg 
Km 
μM 
Vmax 
nmol/min/mg 
Km 
μM 
Wild-type 313 ± 8  34 ± 3   482 ± 15 646 ± 73 
T325A 324 ± 8  48 ± 4 274 ± 9 897 ± 99 
T325D   65 ± 1  15 ± 1   76 ± 1   1084 ± 66 
∆132 ND ND ND ND 
ND, not detectable 
13
Figure 1 
 
14
Figure 2 
 
15
Figure 3 
 
16
Figure 4 
 
17
Figure 5 
 
18
Figure 6 
19
Figure 7 
 
20
